Radiation oncology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS93
Academic Journal
Presents an abstract of the research manuscript `Outcome of palliative radiotherapy for stage III non-small cell lung cancer,' by Jackson S.Y. Wu and Victor Tsang.


Related Articles

  • Palliation in metastatic non-small cell lung cancer: Early integration with standard oncological care is the key. Singh, Navneet; Behera, Digambar // Lung India;Oct-Dec2014, Vol. 31 Issue 4, p317 

    An introduction is presented in which the editor discusses various reports within the issue on lung cancer treatment including chemotherapy, radiation therapy, and palliative care.

  • Palliative Thoracic Radiotherapy in NSCLC. Lester, Jason F. // Current Medical Literature: Lung Cancer;2008, Vol. 1 Issue 4, p105 

    The article discusses the clinical evidence to guide clinicians in deciding when and how to use palliative thoracic radiotherapy non-small-cell lung carcinoma (NSCLC). Advanced NSCLC is the disease included within a radiotherapy (RT) field but extensive for curative treatment, with no showing of...

  • Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. Falk, Stephen J; Girling, David J; White, Roger J; Hopwood, Penelope; Harvey, Angela; Qian, Wendi; Stephens, Richard J // BMJ: British Medical Journal (International Edition);8/31/2002, Vol. 325 Issue 7362, p465 

    Abstract Objective: To determine whether patients with locally advanced non-small cell lung cancer unsuitable for resection or radical radiotherapy, and with minimal thoracic symptoms, should be given palliative thoracic radiotherapy immediately or as needed to treat symptoms. Design:...

  • Cost-Utility Analysis of Short-Versus Long-Course Palliative Radiotherapy in Patients With Non-Small-Cell Lung Cancer. van den Hout, Wilbert B.; Kramer, Gijsbert W. P. M.; Noordijk, Ed M.; Leer, Jan-Willem H. // JNCI: Journal of the National Cancer Institute;12/20/2006, Vol. 98 Issue 24, p1786 

    Background: Radiotherapy can effectively palliate the symptoms of poor-prognosis patients with non-small-cell lung cancer. However, controversy remains about whether short-course or more protracted radiotherapy schedules provide better value for the money. We conducted a societal cost-utility...

  • Lung Cancer.  // Current Medical Literature: Respiratory Medicine;2010, Vol. 24 Issue 4, p110 

    No abstract available.

  • Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature. Beli, I.; Koukourakis, G.; Platoni, K.; Tolia, M.; Kelekis, N.; Kouvaris, J.; Syrigos, C.; Mystakidou, K.; Varveris, C.; Kouloulias, V. // Reviews on Recent Clinical Trials;May2010, Vol. 5 Issue 2, p103 

    Hypofractionated irradiation has an established role in the palliative treatment of patients with advanced medically inoperable non - small cell lung cancer (NSCLC) and poor performance status. Also hypofractionated radiotherapy merits careful consideration in the curative treatment of patients...

  • Lung cancer treatment and palliation.  // Thorax;Dec2004 Supplement, Vol. 59, p52 

    The article presents some papers related to lung cancer treatment and palliation. Concurrent chemoradiotherapy may be the most effective form of treatment for some patients with locally advanced inoperable non-small cell lung cancer (NSCLC). The causative relationship between thoracic...

  • A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Senkus-Konefka, E.; Dziadziuszko, R.; Bednaruk-Młyński, E.; Pliszka, A.; Kubrak, J.; Lewandowska, A.; Małachowski, K.; Wierzchowski, M.; Matecka-Nowak, M.; Jassem, J. // British Journal of Cancer;3/28/2005, Vol. 92 Issue 6, p1038 

    A prospective randomised study compared two palliative radiotherapy schedules for inoperable symptomatic non-small-cell lung cancer (NSCLC). After stratification, 100 patients were randomly assigned to 20?Gy/5 fractions (fr)/5 days (arm A) or 16?Gy/2 fr/day 1 and 8 (arm B). There were 90 men and...

  • Palliative care in patients with lung cancer. Farbicka, Paulina; Nowicki, Andrzej // Contemporary Oncology / Wspolczesna Onkologia;2013, Vol. 17 Issue 3, p238 

    Lung cancer accounts for 12% of all cancers and has the highest annual rate of mortality in men and women. The overall aimis cure or prolongation of life without evidence of disease. Almost 60% of patients at the moment of diagnosis are not eligible for radical treatment. Therefore soothing and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics